Infliximab infusion reactions: desensitizing ourselves to the danger.
Persley
Kimberly M
KM
University of Texas, Southwestern Medical Center, USA.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000209:etiology / Q000517:prevention & control*; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D012189:Retrospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab